Postmarketing Assessment of Antibody-Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach.

Asiimwe IG, Chtiba N, Mouksassi S, Pillai GC, Peter RM, Yuen E, Pilla Reddy V

Open source

DOI
10.1002/psp4.70013
Published
2025 Nov
Container
CPT: pharmacometrics & systems pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/psp4.70013,
  title = {Postmarketing Assessment of Antibody-Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach.},
  author = {Asiimwe IG and Chtiba N and Mouksassi S and Pillai GC and Peter RM and Yuen E and Pilla Reddy V},
  year = {2025},
  journal = {CPT: pharmacometrics \& systems pharmacology},
  doi = {10.1002/psp4.70013},
  url = {https://doi.org/10.1002/psp4.70013}
}

RIS

TY  - JOUR
TI  - Postmarketing Assessment of Antibody-Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach.
AU  - Asiimwe IG
AU  - Chtiba N
AU  - Mouksassi S
AU  - Pillai GC
AU  - Peter RM
AU  - Yuen E
AU  - Pilla Reddy V
PY  - 2025
JO  - CPT: pharmacometrics & systems pharmacology
DO  - 10.1002/psp4.70013
UR  - https://doi.org/10.1002/psp4.70013
ER  - 

APA

IG, A., N, C., S, M., GC, P., RM, P., E, Y., & V, P. R. (2025). Postmarketing Assessment of Antibody-Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach.. CPT: pharmacometrics & systems pharmacology. https://doi.org/10.1002/psp4.70013

Source records